Advertisement
DHR vs RVTY
Which Stock Would AI Choose? Danaher Corporation (DHR) vs. Revvity, Inc. (RVTY) Stock Comparison
Key Takeaways
- DHR (Danaher Corporation) operates at significantly larger scale with a market capitalization exceeding $138 billion, compared to RVTY (Revvity, Inc.) at approximately $12 billion, providing broader diversification across life sciences and diagnostics.
- Recent market activity shows DHR delivering stronger year-to-date performance in several reports, with notable recovery from earlier 2026 weakness following Q1 earnings and raised full-year guidance.
- RVTY posted Q1 2026 revenue of $711 million with adjusted EPS of $1.06, beating estimates on the bottom line while adjusting full-year pro forma revenue guidance slightly lower amid portfolio optimization efforts.
- Both companies face similar sector exposure in life sciences and diagnostics, but DHR benefits from stronger operating cash flow and free cash flow generation, supporting consistent shareholder returns including quarterly dividends.
- Market sentiment reflects DHR’s larger analyst price targets around $242, indicating perceived stability, while RVTY trades with more modest momentum amid organic growth challenges in certain regions.
- Relative positioning favors DHR for investors seeking scale and cash-flow consistency, whereas RVTY may appeal to those focused on targeted innovation and valuation metrics.
Introduction
This comparison examines DHR and RVTY, two companies operating in the life sciences and diagnostics sector. The analysis highlights differences in business scale, recent financial results, and market positioning to assist traders and investors evaluating relative performance in the current environment. Institutional and retail participants monitoring healthcare equipment, bioprocessing, and diagnostic tools may find the review relevant when assessing portfolio allocations or tactical trading decisions within the broader equity market.
DHR Overview and Recent Performance
Danaher Corporation develops and manufactures products in life sciences, diagnostics, and environmental and applied solutions. In recent market activity, DHR shares have shown resilience, with year-to-date gains reported around 14-16% amid recovery from earlier 2026 pressure. The company delivered first-quarter 2026 results with revenues of $6.0 billion, up 3.5% year-over-year, and raised full-year adjusted diluted EPS guidance to a range of $8.35 to $8.55. Strong operating cash flow of $1.3 billion and non-GAAP free cash flow of $1.1 billion supported sentiment. Recent weeks included a regular quarterly dividend declaration of $0.40 per share, reflecting consistent capital return policies. Performance has been influenced by bioprocessing demand and integration activities, contributing to improved stability relative to broader market indices in select periods.
RVTY Overview and Recent Performance
Revvity, Inc. provides solutions in life sciences, diagnostics, and applied markets, with a focus on reagents, instruments, and software. In recent market activity, RVTY shares have posted year-to-date returns near 13%, with the stock closing around $109 amid modest fluctuations. First-quarter 2026 results showed revenue of $711 million, up 7% year-over-year, alongside adjusted EPS from continuing operations of $1.06 that exceeded consensus estimates. The company adjusted full-year pro forma revenue guidance to $2.81-$2.84 billion while maintaining pro forma adjusted EPS outlook of $5.20-$5.30. Recent developments include ongoing portfolio pruning and investments in AI-driven tools. Market positioning reflects steady demand in core segments offset by regional pressures, resulting in measured momentum compared with larger peers.
Trending AI Robots
Tickeron’s Trending AI Robots page curates a selection of high-performing AI trading bots from hundreds available across the platform. These bots trade thousands of different tickers using varied strategies, timeframes, and performance metrics tailored to prevailing market conditions. Only the strongest and most suitable models earn placement in the trending section, where users can review detailed statistics including win rates, drawdowns, and profitability ranges that often span from conservative single-digit monthly returns to more aggressive profiles exceeding 10-20% in favorable periods. All AI trading bots differ in trading styles, risk parameters, and ticker focus. Review the full selection on the Trending AI Robots page for current options aligned with individual objectives.
Head-to-Head Comparison
DHR and RVTY share exposure to life sciences and diagnostics but differ markedly in scale and execution. DHR’s larger market capitalization supports greater diversification and cash generation, evidenced by robust quarterly free cash flow that funds dividends and acquisitions. RVTY, with a smaller footprint, emphasizes targeted portfolio adjustments and software innovations, which can introduce higher sensitivity to regional revenue shifts such as those observed in international markets. Recent momentum favors DHR following earnings-driven guidance increases, while RVTY demonstrates EPS resilience despite modest revenue adjustments. Risk factors include acquisition integration for DHR and organic growth variability for RVTY. Sector tailwinds in bioprocessing and diagnostics apply to both, yet DHR’s established position typically translates to lower volatility in sentiment shifts compared with RVTY’s more concentrated exposure.
Tickeron AI Verdict
Based on observable factors including scale, cash-flow consistency, and recent guidance momentum, Tickeron’s AI would currently assign a higher probabilistic preference to DHR over RVTY. The larger company’s trend stability and broader positioning provide a more consistent profile amid sector dynamics, while RVTY offers potential upside tied to operational refinements but with comparatively narrower buffers. This assessment draws from relative performance patterns and does not constitute investment advice.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a StrongBuy and RVTY is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DHR’s FA Score shows that 1 FA rating(s) are green whileRVTY’s FA Score has 3 green FA rating(s).
- DHR’s FA Score: 1 green, 4 red.
- RVTY’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DHR’s TA Score shows that 6 TA indicator(s) are bullish while RVTY’s TA Score has 4 bullish TA indicator(s).
- DHR’s TA Score: 6 bullish, 4 bearish.
- RVTY’s TA Score: 4 bullish, 5 bearish.
Price Growth
DHR (@Medical Specialties) experienced а +0.57% price change this week, while RVTY (@Medical Specialties) price change was -1.29% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -0.81%. For the same industry, the average monthly price growth was +11.88%, and the average quarterly price growth was +7.07%.
Reported Earning Dates
DHR is expected to report earnings on Jul 21, 2026.
RVTY is expected to report earnings on Aug 04, 2026.
Industries' Descriptions
@Medical Specialties (-0.81% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| DHR | RVTY | DHR / RVTY | |
| Capitalization | 141B | 12.5B | 1,128% |
| EBITDA | 7.08B | 773M | 916% |
| Gain YTD | -12.682 | 16.223 | -78% |
| P/E Ratio | 38.58 | 53.99 | 71% |
| Revenue | 24.8B | 2.9B | 855% |
| Total Cash | N/A | 860M | - |
| Total Debt | 18.5B | 3.35B | 552% |
DHR | RVTY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 75 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 10 Undervalued | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 80 | 89 | |
PRICE GROWTH RATING 1..100 | 52 | 21 | |
P/E GROWTH RATING 1..100 | 54 | 28 | |
SEASONALITY SCORE 1..100 | 19 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DHR's Valuation (10) in the Medical Specialties industry is in the same range as RVTY (15). This means that DHR’s stock grew similarly to RVTY’s over the last 12 months.
DHR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as RVTY (100). This means that DHR’s stock grew similarly to RVTY’s over the last 12 months.
DHR's SMR Rating (80) in the Medical Specialties industry is in the same range as RVTY (89). This means that DHR’s stock grew similarly to RVTY’s over the last 12 months.
RVTY's Price Growth Rating (21) in the Medical Specialties industry is in the same range as DHR (52). This means that RVTY’s stock grew similarly to DHR’s over the last 12 months.
RVTY's P/E Growth Rating (28) in the Medical Specialties industry is in the same range as DHR (54). This means that RVTY’s stock grew similarly to DHR’s over the last 12 months.
| DHR | RVTY | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 47% | 3 days ago 71% |
| Stochastic ODDS (%) | 3 days ago 71% | 3 days ago 75% |
| Momentum ODDS (%) | 3 days ago 57% | 3 days ago 73% |
| MACD ODDS (%) | 3 days ago 64% | 3 days ago 70% |
| TrendWeek ODDS (%) | 3 days ago 55% | 3 days ago 67% |
| TrendMonth ODDS (%) | 3 days ago 53% | 3 days ago 61% |
| Advances ODDS (%) | 3 days ago 54% | 11 days ago 64% |
| Declines ODDS (%) | 13 days ago 61% | 5 days ago 67% |
| BollingerBands ODDS (%) | 3 days ago 61% | 3 days ago 68% |
| Aroon ODDS (%) | 3 days ago 48% | 3 days ago 51% |
Advertisement